It’s very good news that the Global Fund is re-opening for business. Now we can stop wasting time, which is the most precious resource in this fight against HIV, TB and malaria, because wasting time is wasting lives. The new funding window at the Global Fund needs to be opened as soon as possible, be as big as possible, and be open to all affected countries to support treatment scale-up. Now is not the time to be conservative and keep money in the bank that could go toward getting life-saving pills into peoples’ bodies.
The Need For Urgent HIV and TB Treatment in Myanmar.
Tens of thousands of people living with HIV and tuberculosis (TB) in Myanmar are unable to access lifesaving antiretroviral therapy (ART), a dire situation exacerbated by the recent cancellation of a new round of funding from the Global Fund to Fight AIDS, TB, and Malaria.
“Lives in the Balance,” a new report from Doctors Without Borders/Médecins Sans Frontières (MSF), outlines the situation for people affected by HIV and tuberculosis (TB), with a special focus on multidrug-resistant TB (MDR-TB), in Myanmar today. It calls for urgent funding and assistance to be made available by the international donor community to help Myanmar close the devastating gap between people’s need and people’s access to treatment for HIV and TB.
Infographic by Will Owen
Myanmar: Urgent Action Needed Against HIV and TB
Between 15,000 and 20,000 people living with HIV die every year in Myanmar because of lack of access to lifesaving ART. TB prevalence in Myanmar is more than three times the global average and Myanmar is among the 27 countries with the highest MDR-TB rates in the world. Like non-resistant TB, MDR-TB is easily transmitted through the air and can infect perfectly healthy people, but requires far more complex and lengthy treatment.
MSF currently treats more than 23,000 HIV patients in Myanmar. An additional 6,000 people will be enrolled in MSF clinics in 2012. Worlwide, MSF treats more than 170,000 people living with HIV.
Photo: Myanmar 2012 © Greg Constantine.
A young man co-infected with HIV and TB at MSF’s clinic in Yangon.
Leaving people without drugs is like tying a rope round a person’s neck

Charles, a Kenyan who benefits from access to vital medications that are at risk of being cut off.
Join in on the action and tweet this line:
Help #MSF protect access to affordable meds, tell @Novartis to drop its case vs #India http://ow.ly/8XPoQ #STOPnovartis
KILLING THOUSANDS TO MAKE MILLIONS
In days, a multi-billion dollar Swiss pharma company may get the Indian Supreme Court to shut down our supply of affordable medicines. Only we can stop this outrage.
Novartis is suing [the Indian] government so it can squeeze more profits from the sick and needy. If Novartis wins, it will threaten Indian companies’ ability to produce low-cost medicines for malaria, AIDS, cancer and other life-threatening diseases, depriving millions around the world of the treatments they desperately need and threatening thousands of Indian jobs. But people power can push Novartis to drop the suit before the final ruling. Learn more.
Over the past few years the sense of urgency which once defined the work of the fund has become greatly diminished, and the board basically gave themselves a holiday instead of stepping up and doing their job and ensuring that the funding shortfall was made up. On the one hand, they have a new ambitious strategy for change; and on the other, they have effectively closed for business. And it is this lack of coherence that we find troubling – and patients will come to find deadly.
Sharonann Lynch,
MSF HIV Adviser speaking to the Global Fund regarding it’s legacy and future.
As Global Fund Turns Ten, Lack of Political Support to Health Threatens Gains Against AIDS, TB, and Malaria
Pictured above: A woman receives antiretroviral medication at an MSF clinic in Cape Town. While MSF relies solely on private donors, a loss of funding from the Global Fund will leave thousands without treatment.
More on the situation here.
Photo:South Africa 2011 © Chelsea Maclachlan/Le Monde
If nothing is done, it is highly likely that the 15,000 people currently on the waiting list and in urgent need of ARV drugs will be dead within three years. As horrifying as that number is, it represents only the tip of the iceberg when you realize that most people living with HIV/AIDS in DRC do not know their HIV status. Many will die in silence and neglect.
I have worked with HIV-positive patients in many countries in central and southern Africa, but what I’m seeing in the Democratic Republic of Congo has not existed elsewhere for years. The situation here reminds me of the time before any antiretroviral (ARV) treatment was available. Our doctors face serious complications every day that could be prevented if patients received early ARV treatment.
This commitment today is the shot in the arm that the global HIV/AIDS response needs right now. We hope this marks the end of donors walking away from supporting global HIV/AIDS, despite evidence that the epidemic can be reversed. People living with HIV around the world will be watching Congress closely until it approves President Obama’s budget request to help turn this commitment into reality. Now it is time for all governments – both donors and affected countries alike – to step up, fund the Global Fund, and increase the pace of HIV treatment scale-up, so that the effort to end AIDS is not derailed.
Our doctors and nurses started treating people with HIV in developing countries a decade ago, in the face of widespread skepticism, and yet today half of the people who need treatment now have it. This is the best time to charge full speed ahead and get treatment to everyone who needs it so we can save lives and get ahead of the wave of new infections.
LIVE: Join us in watching President Obama’s remarks on World AIDS Day.
It’s very gratifying to see how grateful the patients are for the care and attention we give them. Our input isn’t only medical; it also consists of moral support, as many of the patients are having a hard time and have lost their hope in life. Seeing them regain their confidence and strength is really rewarding.
Right now, we’re in an absurd situation where the signposts all point in one direction to get a handle on HIV/AIDS, yet the funding crunch is pulling us the opposite way. We have to act fast and reach as many people as possible to save lives and avoid slipping back, but countries can’t do this alone.
We go and find them in their villages and offer extra support for them to come back for their appointment, then we follow up and ensure they are taking their drugs correctly, but we also visit patients when they are at a critical point of their treatment or are experiencing side effects and need more support.
Meeting with patients at an MSF clinic in southern Myanmar.
In this article, Dr. Calorine Mekiedje talks about her experience as a medical adviser at the Dawei clinic in the south of Myanmar, where MSF has been treating HIV/AIDS and tuberculosis (TB) since 2000.
Photo: Myanmar 2011 © Veronique Terrasse/MSF